Market size- Industry Trends & Outlook Report 2026
Market worth was estimated USD 13.7 billion in 2019, and it is expected to
reach USD 24.09 billion by 2026 at a CAGR of 8.4% during the projection period.
The Global Transplantation Market thrives on the need for organ transplants and
demand for tissue products, immunosuppressant drugs and organ preservation.
Technological advancements further support market growth. The high success rate
of transplantation enhances the demand for tissue and organ transplantation
services. A large part of the global population suffers from different diseases
such as diabetes, cardiovascular disease, pulmonary diseases, cancer or renal
diseases, leading to organ and tissue failure requiring transplantation. The market
players provide organ and tissue procurement and preservation for meeting the
requirement of transplantation. Rising regulatory approvals for innovative
products and new guidelines for organ donations also improve market prospects.
However, market growth is impeded by limited organ supply, organ rejection and
high costs of treatment.
refers to the medical procedure of removing an organ from
one body and placing the same in the body of the recipient to replace the
failed organ. Multiple organs viz., heart, lung, liver, skin, pancreas, kidney,
cornea, can be transplanted. Transplants are essential to lead a healthy life
in case of organ and tissue damage. Technological advancements in application
and product have led to more successful transplants. The surge has been noticed
in tissue transplant with advancements in medical biotechnology. Advanced
tissue products such as Dutra matrix Collagen Dura Substitute Membrane and
DeNovo NT Graft are beneficial in treatment. Besides, the advance software and
systems allow easy and effective maintenance of tissues. Many companies of
different scales are engaged in providing products and services related
transplants. They form alliances for expanding their reach and introduce
advanced products to cater to the transplant requirements.
Prevalence of Chronic
Diseases and Organ Failures
The prevalence of chronic
and acute diseases eventually leads to organ or tissue failures, requiring
transplantation. The critical reasons for organ failure are loss of blood,
leukemia, sepsis, drug abuse, severe trauma, among others. Besides, the
patients and medical professionals are increasingly adopting transplantation
due to its high success rate. In many diseases, as mentioned above, the
transplantation gives a new life. New diseases are also being treated with
transplants with the advancement of transplant science. The growing incidence
of these diseases among large population ensures the growth of transplantation
market during the projected period.
has witnessed tremendous advancements in the form of 3D Bio-Printing and
Biological & mechanical communication. Through these forms, the researchers
and scientists are creating human organs and designing artificial limbs,
contributing to successful transplantation procedures. The advancements in
procurement and preservation of tissues and organs coupled with a rising number
of tissue banks have also augmented transplantation services, propelling the
growth of the market. Also, the launch of new technological products is
expected to enhance the number of transplant procedures for tissues, lungs,
kidneys, liver, heart and lungs.
market is limited by the number of organ donors, organ-matching and high costs associated
with the same. Many transplants require matching of the organs, particularly
kidney transplants, which is not attainable in every case. Also, the
transplantation market is driven by the availability of organs and organ
donors, and the restriction on it leads to impeding the market. Lack of
awareness and traditional beliefs prevent organ donations by a large number of
people. Besides, the risk of organ rejection also enhances the risk and limits
Impact of COVID-19 in
The economies world over
are going the pandemic crisis, leading to shrinkage of production, operations
and availability of various goods & services. The economic activities have
been adversely affected due to restrictions on transportation, supply chain disruptions
and distribution network suspensions or delays. Medical professionals are also
given guidelines for performing urgent transplantations from the respective
medical professional bodies in times of coronavirus spread. They are taking the
utmost care while performing surgeries or postponing surgeries as far as
possible. However, growing organ failures conditions are expected to need more
Transplantation market is segmented into Product Type, Application Type,
End-Use and Region. Based on Product Type, it is again divided into Tissue
Products, Immunosuppressive Drugs and Preservation Solutions. The Tissue
product segment is the dominating one with a vital share in revenues and is
expected to grow at substantial CAGR because of the high demand and advancements
of the products during the projection period. The rising number of
cochlear, orthopedics soft tissues, heart valves and bone marrow
transplantation procedures combined with new product development propel the
tissue product demand. The remaining two
segments in this category are also anticipated to register moderate growth.
Based on Application
Type, the Global Transplantation Market is divided into Organ Transplant and
Tissue Transplant. Tissue transplantation accounts for the significant market
share of over 60% and, is anticipated to record the highest growth during the
projection period due to increasing transplantations of skin, cornea, veins,
tendons, bones, heart valves and nerves. The ever-increasing case of burns and
accidents propel the growth of this segment. Organ Transplant segment is also
anticipated to grow at a significant rate during the forecast period.
Based on End-user, the
market is segregated into Hospitals, Transplant Centers and Others segments.
Hospital segment holds approximately 50% market share and is expected to
maintain the same with the rising number of transplantations performed by the
hospitals during the projection period. The Transplant Centers are anticipated
to witness the highest growth due to the large unmet needs of the patients. The
government initiatives promoting organ donation are further expected to induce
the transplantation market.
North America Healthcare
sector is massive characterized by well-developed healthcare facilities, use of
advanced technology, health-conscious and aware population, substantial
expenditure outlay and major pharmaceutical and healthcare devices
manufacturing companies. It is a major market for transplantation and is
expected to grow substantially because of the presence of key players and
technological advancements. The countries such as Germany, France, UK and
others in European continent are also expected to witness rising number of
transplants due to their advanced healthcare infrastructure. Asia Pacific is also anticipated to register
accelerated CAGR during the projection period on account of growing healthcare
infrastructure, awareness about stem cells and government initiatives in favor
of organ donations.
The leading companies in
the Transplantation Market include Abbvie, Inc., Arthrex, Inc., Medtronic PLC,
Teva Pharmaceuticals, Zimmer Biomet, Strykers, Novartis AG, Veloxis
Pharmaceuticals, 21st Century Medicine, BiolifeSolutions, Inc and others. They
are mostly concentrated in developed countries, particularly North America. Many
small and medium scale companies are scattered across the globe and operate in
the transplantation market. They engage in strategic alliances to strengthen
their market position.
July 15, 2020: BioLife Solutions - a leading developer and supplier of
class-defining bioproduction tools (cell and gene therapies), adopts Evo Cold
Chain Management Platform. The said platform is used for transporting and
monitoring of source material and manufactured doses in more than 100 cell and
gene therapy clinical trials.
June 22, 2020: Transplant Therapeutics Consortium
receives Letter Of Intent from USFDA for acceptance of iBox Scoring System into
Center for Drug Evaluation and Research (CDER) -Biomarker Qualification
Program. It will be used as an endpoint in clinical trials of immunosuppressive
drugs meant for transplantation.
Scope of the Report
data – 2016-2019
Base Year –
2020 – 2026
Revenue in USD Billion
U.S, Canada, Germany, UK,
France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South
Korea UAE, South Africa, Saudi Arabia.
By Product Type, By Application Type, By End-user and By Region.
Abbvie, Inc., Arthrex, Inc., Medtronic PLC,
Teva Pharmaceuticals, Zimmer Biomet, Strykers, Novartis AG, Veloxis
Pharmaceuticals, 21st Century Medicine, BiolifeSolutions, Inc and
By Product Type
Ø Tissue Products
Ø Immunosuppressive Drugs
Ø Preservation Solution
By Application Type
Ø Organ Transplant
Ø Tissue Transplant
By End User Industry
Ø Transplant Centers
Ø Asia Pacific
Ø North America
Ø Middle East & Africa
Ø Latin America
The objective of the Study:
Ø To analyze and forecast the Global Transplantation market size
of the market, in terms of Value.
Ø To examine the market segmentation carefully and project the
market size, in terms value, based on the region by segmenting the Global Transplantation
market into five regions, namely, North America, Europe, Asia Pacific, Latin
America, Middle east & Africa and their leading countries.
Ø To outline, categorize and estimate the Global Transplantation
market based on the application, product, end user and region.
Ø To examine competitive developments in products, applications
and end-user within the Global Transplantation Market.
Ø To highlight the impact analysis of the factors, affecting the
market dynamics such as drivers, restraints, opportunities, and challenges.
Ø To strategically profile the key players and comprehensively
analyze their market shares along with detailed competitive landscape for
Business Questions Answered by the Report:
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client:
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis